Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Teprasiran (QPI-1002) is an RNA-based compound that transiently suppresses p53-dependent apoptosis, a process involved in the development of acute kidney injury (AKI).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Teprasiran (QPI-1002) is an RNA-based compound that transiently suppresses p53-dependent apoptosis, a process involved in the development of acute kidney injury (AKI). |
In vitro | Teprasiran is a synthetic, chemically stabilized small interfering RNA (siRNA) that operates via RNA interference to transiently suppress p53 expression for approximately 48 to 72 hours[1]. |
Synonyms | QPI-1002 |
Molecular Weight | N/A |
CAS No. | 1231737-88-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Teprasiran 1231737-88-4 QPI-1002 QPI 1002 QPI1002 inhibitor inhibit